FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000314855> ?p ?o ?g. }

• W2000314855 endingPage "116" @default.
• W2000314855 startingPage "109" @default.
• W2000314855 abstract "<i>Background:</i> The optimal management of patients with cryptogenic ischemic stroke found to have a patent foramen ovale (PFO) at diagnostic workup remains unclear. The aims of this observational multicenter study were to evaluate: (1) the risk of recurrent cerebrovascular events in patients with cryptogenic minor ischemic stroke or transient ischemic attack (TIA) and PFO who either underwent percutaneous PFO closure or received only medical treatment, and (2) the risk factors associated with recurrent events. <i>Methods:</i> Consecutive patients (aged 55 years or less) with first-ever cryptogenic minor ischemic stroke or TIA and PFO were recruited in 13 Italian hospitals between January 2006 and September 2007 and followed up for 2 years. <i>Results:</i> 238 patients were included in the study (mean age 42.2 ± 10.0 years; 118 males); 117 patients (49.2%) received only antithrombotic therapy while 121 patients underwent percutaneous PFO closure (50.8%). Stroke as the qualifying event was more common in the medical treatment group (p = 0.01). The presence of atrial septal aneurysm and evidence of 20 bubbles or more on transcranial Doppler were more common in the PFO closure group (p = 0.002 and 0.02). Eight patients (6.6%) experienced a nonfatal complication during PFO closure. At the 2-year follow-up, 17 recurrent events (TIA or stroke; 3.6% per year) were observed; 7 of these events (2.9% per year) occurred in the percutaneous PFO closure group and 10 events (4.2% per year) in the medical treatment group. The rate of recurrent stroke was 0.4% per year in patients who underwent percutaneous closure (1 event) and 3.4% per year in patients who received medical treatment (8 events). On multivariate analysis, percutaneous closure was not protective in preventing recurrent TIA or stroke (OR = 0.1, 95% CI = 0.02–1.5, p = 0.1), while it was barely protective in preventing recurrent stroke (OR = 0.1, 95% CI = 0.0–1.0, p = 0.053). <i>Conclusions:</i> The results of this observational, nonrandomized study suggest that PFO closure might be superior to medical therapy for the prevention of recurrent stroke. Periprocedural complications were the trade-off for this clinical benefit. Controlled randomized clinical trials comparing percutaneous closure with medical management are required." @default.
• W2000314855 created "2016-06-24" @default.
• W2000314855 creator A5001994815 @default.
• W2000314855 creator A5004271759 @default.
• W2000314855 creator A5007176843 @default.
• W2000314855 creator A5017701626 @default.
• W2000314855 creator A5022472213 @default.
• W2000314855 creator A5022665738 @default.
• W2000314855 creator A5023315895 @default.
• W2000314855 creator A5025237260 @default.
• W2000314855 creator A5037097915 @default.
• W2000314855 creator A5037529512 @default.
• W2000314855 creator A5043069872 @default.
• W2000314855 creator A5046622037 @default.
• W2000314855 creator A5049328868 @default.
• W2000314855 creator A5050506462 @default.
• W2000314855 creator A5051285441 @default.
• W2000314855 creator A5051371568 @default.
• W2000314855 creator A5052696387 @default.
• W2000314855 creator A5054783539 @default.
• W2000314855 creator A5056123460 @default.
• W2000314855 creator A5058622059 @default.
• W2000314855 creator A5062888332 @default.
• W2000314855 creator A5065727519 @default.
• W2000314855 creator A5076768992 @default.
• W2000314855 creator A5081836436 @default.
• W2000314855 creator A5087139584 @default.
• W2000314855 creator A5088674770 @default.
• W2000314855 creator A5089967868 @default.
• W2000314855 creator A5090401759 @default.
• W2000314855 date "2010-11-17" @default.
• W2000314855 modified "2023-10-13" @default.
• W2000314855 title "Risk of Recurrent Cerebrovascular Events in Patients with Cryptogenic Stroke or Transient Ischemic Attack and Patent Foramen Ovale: The FORI (Foramen Ovale Registro Italiano) Study" @default.
• W2000314855 cites W1966972223 @default.
• W2000314855 cites W1971196515 @default.
• W2000314855 cites W1980996793 @default.
• W2000314855 cites W1987659490 @default.
• W2000314855 cites W1994580388 @default.
• W2000314855 cites W2010050468 @default.
• W2000314855 cites W2018627259 @default.
• W2000314855 cites W2021556603 @default.
• W2000314855 cites W2026580042 @default.
• W2000314855 cites W2034543700 @default.
• W2000314855 cites W2039718841 @default.
• W2000314855 cites W2059174305 @default.
• W2000314855 cites W2061835461 @default.
• W2000314855 cites W2063740149 @default.
• W2000314855 cites W2080307360 @default.
• W2000314855 cites W2081838119 @default.
• W2000314855 cites W2085057549 @default.
• W2000314855 cites W2089933125 @default.
• W2000314855 cites W2104024477 @default.
• W2000314855 cites W2109328150 @default.
• W2000314855 cites W2121187530 @default.
• W2000314855 cites W2126225 @default.
• W2000314855 cites W2151720801 @default.
• W2000314855 cites W2152862288 @default.
• W2000314855 cites W2153488905 @default.
• W2000314855 cites W2171015235 @default.
• W2000314855 cites W2242821813 @default.
• W2000314855 cites W2326526061 @default.
• W2000314855 cites W2357418238 @default.
• W2000314855 doi "https://doi.org/10.1159/000321334" @default.
• W2000314855 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21088390" @default.
• W2000314855 hasPublicationYear "2010" @default.
• W2000314855 type Work @default.
• W2000314855 sameAs 2000314855 @default.
• W2000314855 citedByCount "45" @default.
• W2000314855 countsByYear W20003148552012 @default.
• W2000314855 countsByYear W20003148552013 @default.
• W2000314855 countsByYear W20003148552014 @default.
• W2000314855 countsByYear W20003148552015 @default.
• W2000314855 countsByYear W20003148552016 @default.
• W2000314855 countsByYear W20003148552018 @default.
• W2000314855 countsByYear W20003148552019 @default.
• W2000314855 countsByYear W20003148552020 @default.
• W2000314855 countsByYear W20003148552021 @default.
• W2000314855 crossrefType "journal-article" @default.
• W2000314855 hasAuthorship W2000314855A5001994815 @default.
• W2000314855 hasAuthorship W2000314855A5004271759 @default.
• W2000314855 hasAuthorship W2000314855A5007176843 @default.
• W2000314855 hasAuthorship W2000314855A5017701626 @default.
• W2000314855 hasAuthorship W2000314855A5022472213 @default.
• W2000314855 hasAuthorship W2000314855A5022665738 @default.
• W2000314855 hasAuthorship W2000314855A5023315895 @default.
• W2000314855 hasAuthorship W2000314855A5025237260 @default.
• W2000314855 hasAuthorship W2000314855A5037097915 @default.
• W2000314855 hasAuthorship W2000314855A5037529512 @default.
• W2000314855 hasAuthorship W2000314855A5043069872 @default.
• W2000314855 hasAuthorship W2000314855A5046622037 @default.
• W2000314855 hasAuthorship W2000314855A5049328868 @default.
• W2000314855 hasAuthorship W2000314855A5050506462 @default.
• W2000314855 hasAuthorship W2000314855A5051285441 @default.
• W2000314855 hasAuthorship W2000314855A5051371568 @default.
• W2000314855 hasAuthorship W2000314855A5052696387 @default.
• W2000314855 hasAuthorship W2000314855A5054783539 @default.
• W2000314855 hasAuthorship W2000314855A5056123460 @default.
• W2000314855 hasAuthorship W2000314855A5058622059 @default.

• next